BSEM CIK: 1658678

BioStem Technologies, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY20
FY21
FY22
FY23
FY24
FY20 – FY24

Assets

(positive)
Change from FY20 to FY24
millions USD
FY20:
0.85
FY21:
0.94
FY22:
1.49
FY23:
12.6
FY24:
134
(positive)
Change from FY20 to FY24
millions USD
FY20:
1.82
FY21:
1.73
FY22:
1.98
FY23:
1.96
FY24:
6.61
Total assets
Change from FY20 to FY24
millions USD
FY20:
2.67
FY21:
2.67
FY22:
3.47
FY23:
14.6
FY24:
140

Liabilities & Equity

(negative)
Change from FY20 to FY24
millions USD
FY20:
6.80
FY21:
6.54
FY22:
6.33
FY23:
15.6
FY24:
99.2
(negative)
Change from FY20 to FY24
millions USD
FY20:
1.50
FY21:
1.92
FY22:
1.09
FY23:
0.28
FY24:
0.33
(positive)
Change from FY20 to FY24
millions USD
FY20:
−5.63
FY21:
−5.79
FY22:
−3.95
FY23:
−1.34
FY24:
40.9
Total liabilities & equity
Change from FY20 to FY24
millions USD
FY20:
2.67
FY21:
2.67
FY22:
3.47
FY23:
14.6
FY24:
140

All amounts in millions USD Data source:Twelve Data